Tyrosine kinases in inflammatory dermatologic disease

Ricardo T. Paniagua, David F. Fiorentino, Lorinda Chung, William H. Robinson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Tyrosine kinases (TKs) are enzymes that catalyze the phosphorylation of tyrosine residues on protein substrates. They are key components of signaling pathways that drive an array of cellular responses including proliferation, differentiation, migration, and survival. Specific TKs have recently been identified as critical to the pathogenesis of several autoimmune and inflammatory diseases. Small-molecule inhibitors of TKs are emerging as a novel class of therapy that may provide benefit in certain patient subsets. In this review, we highlight TK signaling implicated in inflammatory dermatologic diseases, evaluate strategies aimed at inhibiting these aberrant signaling pathways, and discuss prospects for future drug development.

Original languageEnglish (US)
Pages (from-to)389-403
Number of pages15
JournalJournal of the American Academy of Dermatology
Volume65
Issue number2
DOIs
StatePublished - Aug 2011

Fingerprint

Protein-Tyrosine Kinases
Autoimmune Diseases
Tyrosine
Phosphorylation
Survival
Enzymes
Pharmaceutical Preparations
Proteins
Therapeutics

Keywords

  • autoimmune
  • dermatology
  • dermatomyositis
  • fibrosis
  • inflammatory
  • pemphigus
  • phosphorylation
  • psoriasis
  • tyrosine kinase

ASJC Scopus subject areas

  • Dermatology

Cite this

Tyrosine kinases in inflammatory dermatologic disease. / Paniagua, Ricardo T.; Fiorentino, David F.; Chung, Lorinda; Robinson, William H.

In: Journal of the American Academy of Dermatology, Vol. 65, No. 2, 08.2011, p. 389-403.

Research output: Contribution to journalArticle

Paniagua, RT, Fiorentino, DF, Chung, L & Robinson, WH 2011, 'Tyrosine kinases in inflammatory dermatologic disease', Journal of the American Academy of Dermatology, vol. 65, no. 2, pp. 389-403. https://doi.org/10.1016/j.jaad.2010.04.026
Paniagua, Ricardo T. ; Fiorentino, David F. ; Chung, Lorinda ; Robinson, William H. / Tyrosine kinases in inflammatory dermatologic disease. In: Journal of the American Academy of Dermatology. 2011 ; Vol. 65, No. 2. pp. 389-403.
@article{1576c0f5e3614beabdfd2b5b44fc87b9,
title = "Tyrosine kinases in inflammatory dermatologic disease",
abstract = "Tyrosine kinases (TKs) are enzymes that catalyze the phosphorylation of tyrosine residues on protein substrates. They are key components of signaling pathways that drive an array of cellular responses including proliferation, differentiation, migration, and survival. Specific TKs have recently been identified as critical to the pathogenesis of several autoimmune and inflammatory diseases. Small-molecule inhibitors of TKs are emerging as a novel class of therapy that may provide benefit in certain patient subsets. In this review, we highlight TK signaling implicated in inflammatory dermatologic diseases, evaluate strategies aimed at inhibiting these aberrant signaling pathways, and discuss prospects for future drug development.",
keywords = "autoimmune, dermatology, dermatomyositis, fibrosis, inflammatory, pemphigus, phosphorylation, psoriasis, tyrosine kinase",
author = "Paniagua, {Ricardo T.} and Fiorentino, {David F.} and Lorinda Chung and Robinson, {William H.}",
year = "2011",
month = "8",
doi = "10.1016/j.jaad.2010.04.026",
language = "English (US)",
volume = "65",
pages = "389--403",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Tyrosine kinases in inflammatory dermatologic disease

AU - Paniagua, Ricardo T.

AU - Fiorentino, David F.

AU - Chung, Lorinda

AU - Robinson, William H.

PY - 2011/8

Y1 - 2011/8

N2 - Tyrosine kinases (TKs) are enzymes that catalyze the phosphorylation of tyrosine residues on protein substrates. They are key components of signaling pathways that drive an array of cellular responses including proliferation, differentiation, migration, and survival. Specific TKs have recently been identified as critical to the pathogenesis of several autoimmune and inflammatory diseases. Small-molecule inhibitors of TKs are emerging as a novel class of therapy that may provide benefit in certain patient subsets. In this review, we highlight TK signaling implicated in inflammatory dermatologic diseases, evaluate strategies aimed at inhibiting these aberrant signaling pathways, and discuss prospects for future drug development.

AB - Tyrosine kinases (TKs) are enzymes that catalyze the phosphorylation of tyrosine residues on protein substrates. They are key components of signaling pathways that drive an array of cellular responses including proliferation, differentiation, migration, and survival. Specific TKs have recently been identified as critical to the pathogenesis of several autoimmune and inflammatory diseases. Small-molecule inhibitors of TKs are emerging as a novel class of therapy that may provide benefit in certain patient subsets. In this review, we highlight TK signaling implicated in inflammatory dermatologic diseases, evaluate strategies aimed at inhibiting these aberrant signaling pathways, and discuss prospects for future drug development.

KW - autoimmune

KW - dermatology

KW - dermatomyositis

KW - fibrosis

KW - inflammatory

KW - pemphigus

KW - phosphorylation

KW - psoriasis

KW - tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=79960397964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960397964&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2010.04.026

DO - 10.1016/j.jaad.2010.04.026

M3 - Article

C2 - 20584561

AN - SCOPUS:79960397964

VL - 65

SP - 389

EP - 403

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -